Skip to content
Methodology
All entries for: Amgen Inc.
October 16, 2025
Amgen Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of systemic sclerosis
Disease Area:
Rare Diseases
Source
Scroll to Top
